Identification of 38 novel loci for systemic lupus erythematosus and genetic heterogeneity between ancestral groups.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 33536424.
- Also identified by DOI 10.1038/s41467-021-21049-y and PMC identifier 7858632.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Systemic lupus erythematosus (SLE), a worldwide autoimmune disease with high heritability, shows differences in prevalence, severity and age of onset among different ancestral groups. Previous genetic studies have focused more on European populations, which appear to be the least affected. Consequently, the genetic variations that underlie the commonalities, differences and treatment options in SLE among ancestral groups have not been well elucidated. To address this, we undertake a genome-wide association study, increasing the sample size of Chinese populations to the level of existing European studies. Thirty-eight novel SLE-associated loci and incomplete sharing of genetic architecture are identified. In addition to the human leukocyte antigen (HLA) region, nine disease loci show clear ancestral differences and implicate antibody production as a potential mechanism for differences in disease manifestation. Polygenic risk scores perform significantly better when trained on ancestry-matched data sets. These analyses help to reveal the genetic basis for disparities in SLE among ancestral groups.
Medical subject headings
- Genetic Heterogeneity
- Genetic Predisposition to Disease
- Genome-Wide Association Study
- Lupus Erythematosus, Systemic
- Polymorphism, Single Nucleotide